blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1379677

EP1379677 - PRODUCTION OF HIGH LEVELS OF TRANGENIC FACTOR IX WITHOUT GENE RESCUE, AND ITS THERAPEUTIC USES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  31.03.2006
Database last updated on 16.07.2024
Most recent event   Tooltip31.03.2006Application deemed to be withdrawnpublished on 17.05.2006  [2006/20]
Applicant(s)For all designated states
Progenetics LLC
1872 Pratt Drive, SUite 1400
Blacksburg, VA 24060 / US
[2004/03]
Inventor(s)01 / COOPER, Julian, D.
605 Piedmont Street
Blacksburg, VA 24060 / US
02 / VELANDER, William, Hugold
3014 Lancaster Drive
Blacksburg, VA 24060 / US
03 / O'SICKEY, Tanya, K.
5403 Canon Court
Terre Haute, IN 47803 / US
 [2004/03]
Representative(s)Brookes IP
Windsor House
6-10 Mount Ephraim Road
Tunbridge Wells, Kent TN1 1EE / GB
[N/P]
Former [2004/03]Brookes Batchellor
102-108 Clerkenwell Road
London EC1M 5SA / GB
Application number, filing date02733841.711.03.2002
[2004/03]
WO2002US07532
Priority number, dateUS20010274983P12.03.2001         Original published format: US 274983 P
[2004/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02077161
Date:03.10.2002
Language:EN
[2002/40]
Type: A2 Application without search report 
No.:EP1379677
Date:14.01.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 03.10.2002 takes the place of the publication of the European patent application.
[2004/03]
Search report(s)International search report - published on:US03.04.2003
(Supplementary) European search report - dispatched on:EP23.07.2004
ClassificationIPC:C12P21/00, A01K67/027, A61K38/00
[2004/03]
CPC:
C12N15/8509 (EP,US); A01K67/0275 (EP,US); A01K67/0278 (EP,US);
C07K14/4705 (EP,US); C07K14/721 (EP,US); C07K14/755 (EP,US);
C07K14/8114 (EP,US); C12N9/6432 (EP,US); C12N9/6437 (EP,US);
C12N9/644 (EP,US); C12N9/6464 (EP,US); C12Y304/21006 (EP,US);
C12Y304/21021 (EP,US); C12Y304/21022 (EP,US); C12Y304/21069 (EP,US);
A01K2207/15 (EP,US); A01K2217/00 (EP,US); A01K2217/05 (EP,US);
A01K2227/105 (EP,US); A01K2227/108 (EP,US); A01K2267/01 (EP,US);
A61K38/00 (EP,US); C07K2319/00 (EP,US); C07K2319/80 (EP,US);
C12N2830/008 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/03]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:PRODUKTION HOHER NIVEAUS AN TRANSGENEM FAKTOR IX OHNE GEN-RESCUE UND SEINE THERAPEUTISCHEN VERWENDUNGEN[2004/03]
English:PRODUCTION OF HIGH LEVELS OF TRANGENIC FACTOR IX WITHOUT GENE RESCUE, AND ITS THERAPEUTIC USES[2004/03]
French:PRODUCTION DE NIVEAUX ELEVES DU FACTEUR TRANSGENIQUE IX SANS SAUVETAGE DE GENES, ET SES UTILISATIONS THERAPEUTIQUES[2004/03]
Entry into regional phase10.10.2003National basic fee paid 
10.10.2003Search fee paid 
10.10.2003Designation fee(s) paid 
10.10.2003Examination fee paid 
Examination procedure08.10.2002Request for preliminary examination filed
International Preliminary Examining Authority: US
10.10.2003Examination requested  [2004/03]
11.12.2003Loss of particular rights, legal effect: Claims
26.01.2004Despatch of communication of loss of particular rights: Claims {1}
04.03.2005Despatch of a communication from the examining division (Time limit: M08)
05.11.2005Application deemed to be withdrawn, date of legal effect  [2006/20]
21.12.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/20]
Fees paidRenewal fee
26.03.2004Renewal fee patent year 03
29.03.2005Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PX]  - SABATINO ET AL., "Generation of whey acidic protein promoter-human factor IX transgenic mice for studies of oral tolerance to human factor IX in neonatal hemophilia B mice", BLOOD, (20011116), vol. 98, pages 825A - 826A, XP009033195 [PX] 1 * the whole document *
International search[Y]US4348384  (HORIKOSHI ISAMU, et al);
 [Y]US5476995  (CLARK ANTHONY JOHN [GB], et al);
 [Y]WO9835689  (AMERICAN NAT RED CROSS [US], et al);
 [Y]US6046380  (CLARK ANTHONY JOHN [GB]);
 [Y]  - YULL F. ET AL., "Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice", PROC. NATL. ACAD. SCI. USA, (199511), vol. 92, pages 10899 - 10903, XP002207339

DOI:   http://dx.doi.org/10.1073/pnas.92.24.10899
 [Y]  - CLARK A.J. ET AL., "Expression of human anti-hemophilic factor IX in the milk of transgenic sheep", BIO/TECHNOLOGY, (198905), vol. 7, pages 487 - 492, XP000026727

DOI:   http://dx.doi.org/10.1038/nbt0589-487
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.